These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 29909913)

  • 1. GMP CAR-T cell production.
    Gee AP
    Best Pract Res Clin Haematol; 2018 Jun; 31(2):126-134. PubMed ID: 29909913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CAR T cells - what have we learnt?
    Nat Rev Clin Oncol; 2017 Dec; 15(1):1. PubMed ID: 29242589
    [No Abstract]   [Full Text] [Related]  

  • 3. Closed-system manufacturing of CD19 and dual-targeted CD20/19 chimeric antigen receptor T cells using the CliniMACS Prodigy device at an academic medical center.
    Zhu F; Shah N; Xu H; Schneider D; Orentas R; Dropulic B; Hari P; Keever-Taylor CA
    Cytotherapy; 2018 Mar; 20(3):394-406. PubMed ID: 29287970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of Non-hodgkin Lymphoma.
    Jackson Z; Roe A; Sharma AA; Lopes FBTP; Talla A; Kleinsorge-Block S; Zamborsky K; Schiavone J; Manjappa S; Schauner R; Lee G; Liu R; Caimi PF; Xiong Y; Krueger W; Worden A; Kadan M; Schneider D; Orentas R; Dropulic B; Sekaly RP; de Lima M; Wald DN; Reese JS
    Front Immunol; 2020; 11():1941. PubMed ID: 32849651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CAR T Cells in Trials: Recent Achievements and Challenges that Remain in the Production of Modified T Cells for Clinical Applications.
    Köhl U; Arsenieva S; Holzinger A; Abken H
    Hum Gene Ther; 2018 May; 29(5):559-568. PubMed ID: 29620951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD19 chimeric antigen receptor-redirected T cells combined with epidermal growth factor receptor pathway substrate 8 peptide-derived dendritic cell vaccine in leukemia.
    Wu M; Zhang L; Zhang H; Ning J; Tu S; He Y; Li Y
    Cytotherapy; 2019 Jun; 21(6):659-670. PubMed ID: 31031152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CAR T cells for infection, autoimmunity and allotransplantation.
    Maldini CR; Ellis GI; Riley JL
    Nat Rev Immunol; 2018 Oct; 18(10):605-616. PubMed ID: 30046149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended characterization of anti-CD19 CAR T cell products manufactured at the point of care using the CliniMACS Prodigy system: comparison of donor sources and process duration.
    Malakhova E; Pershin D; Kulakovskaya E; Vedmedskaia V; Fadeeva M; Lodoeva O; Sozonova T; Muzalevskii Y; Kazachenok A; Belchikov V; Shelikhova L; Molostova O; Volkov D; Maschan M
    Cytotherapy; 2024 Jun; 26(6):567-578. PubMed ID: 38493403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma.
    Brown CE; Aguilar B; Starr R; Yang X; Chang WC; Weng L; Chang B; Sarkissian A; Brito A; Sanchez JF; Ostberg JR; D'Apuzzo M; Badie B; Barish ME; Forman SJ
    Mol Ther; 2018 Jan; 26(1):31-44. PubMed ID: 29103912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer Immunotherapy Using Chimeric Antigen Receptor Expressing T-Cells: Present and Future Needs of Clinical Cancer Centers.
    Gotti M; Defrancesco I; D'Angelo M; Basso S; Crotto L; Marinelli A; Maccalli C; Iaconianni V
    Front Immunol; 2020; 11():565236. PubMed ID: 33193333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells.
    Kueberuwa G; Zheng W; Kalaitsidou M; Gilham DE; Hawkins RE
    J Vis Exp; 2018 Oct; (140):. PubMed ID: 30394400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cellular antidote to specifically deplete anti-CD19 chimeric antigen receptor-positive cells.
    Ruella M; Barrett DM; Shestova O; Perazzelli J; Posey AD; Hong SJ; Kozlowski M; Lacey SF; Melenhorst JJ; June CH; Gill SI
    Blood; 2020 Feb; 135(7):505-509. PubMed ID: 31703119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas9 and CAR-T cell, collaboration of two revolutionary technologies in cancer immunotherapy, an instruction for successful cancer treatment.
    Mollanoori H; Shahraki H; Rahmati Y; Teimourian S
    Hum Immunol; 2018 Dec; 79(12):876-882. PubMed ID: 30261221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CAR T-cells for T-cell malignancies: challenges in distinguishing between therapeutic, normal, and neoplastic T-cells.
    Alcantara M; Tesio M; June CH; Houot R
    Leukemia; 2018 Nov; 32(11):2307-2315. PubMed ID: 30315238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adoptive immunotherapy with CAR modified T cells in cancer: current landscape and future perspectives.
    Coscia M; Vitale C; Cerrano M; Maffini E; Giaccone L; Boccadoro M; Bruno B
    Front Biosci (Landmark Ed); 2019 Jun; 24(7):1284-1315. PubMed ID: 31136980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of in vitro potency assays by a resting step for clinical-grade chimeric antigen receptor engineered T cells.
    Wang L; Gong W; Wang S; Neuber B; Sellner L; Schubert ML; Hückelhoven-Krauss A; Kunz A; Gern U; Michels B; Hinkelbein M; Mechler S; Richter P; Müller-Tidow C; Schmitt M; Schmitt A
    Cytotherapy; 2019 May; 21(5):566-578. PubMed ID: 30910382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of chimeric antigen receptor surface expression by a small molecule switch.
    Juillerat A; Tkach D; Busser BW; Temburni S; Valton J; Duclert A; Poirot L; Depil S; Duchateau P
    BMC Biotechnol; 2019 Jul; 19(1):44. PubMed ID: 31269942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CAR-T Cell Therapy in Cancer: Tribulations and Road Ahead.
    Zhang Q; Ping J; Huang Z; Zhang X; Zhou J; Wang G; Liu S; Ma J
    J Immunol Res; 2020; 2020():1924379. PubMed ID: 32411789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Inducible CD19-CAR T Cells with a Tet-On System for Controlled Activity and Enhanced Clinical Safety.
    Gu X; He D; Li C; Wang H; Yang G
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD19 directed CARs in acute lymphoblastic leukemia: state of the art and beyond.
    Quintás-Cardama A
    Leuk Lymphoma; 2019 May; 60(5):1346-1348. PubMed ID: 30646790
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.